| Protein Name |
TRPV2 |
| Gene |
TRPV2 |
| UniProt ID |
Q9Y5S2 |
| Molecular Weight |
~84 kDa (761 amino acids) |
| Subcellular Localization |
Plasma membrane, Endoplasmic reticulum, Lysosomes |
| Protein Family |
TRP (Transient Receptor Potential) channel family, TRPV subfamily |
| Structure |
6 transmembrane domains, tetrameric assembly |
| Associated Diseases |
Alzheimer's Disease, Parkinson's Disease, ALS |
TRPV2 (Transient Receptor Potential Vanilloid 2) is a member of the TRPV (Transient Receptor Potential Vanilloid) subfamily of non-selective calcium-permeable cation channels. The protein is encoded by the TRPV2 gene and plays crucial roles in calcium homeostasis, cellular signaling, and various physiological processes in the nervous system [1][2].
TRPV2 is a ligand-gated channel that can be activated by various stimuli including mechanical stretch, heat, and endogenous bioactive lipids. The channel has been implicated in the pathogenesis of several neurodegenerative diseases, making it a subject of interest for therapeutic development [3][4].
TRPV2 forms a tetrameric channel complex, with each subunit containing:
- Six transmembrane domains (S1-S6)
- N-terminal intracellular tail - Contains ankyrin repeat domains
- C-terminal intracellular tail - Contains regulatory domains
- Pore loop between S5 and S6 - Forms the ion selectivity filter
- Ankyrin Repeat Domain (ARD) - Located in the N-terminus, involved in protein-protein interactions and channel regulation
- TRP Domain - Conserved region linking S6 to the C-terminal tail
- S1-S4 Domain - Forms the voltage sensor-like domain
- S5-S6-Pore Domain - Forms the ion conduction pathway
TRPV2 undergoes several post-translational modifications:
- Phosphorylation - Multiple serine/threonine phosphorylation sites
- Glycosylation - N-linked glycosylation in the extracellular loops
- Palmitoylation - Lipid modifications affecting membrane localization
TRPV2 functions as a non-selective cation channel with permeability to:
- Calcium (PCa/PNa ≈ 1-3)
- Sodium
- Magnesium
- Other monovalent and divalent cations
TRPV2 can be activated by:
- Heat - Noxious temperatures (>52°C)
- Mechanical stretch - Cell membrane deformation
- Endogenous ligands - Lysophospholipids, endocannabinoids
- Chemical activators - 2-APB (2-aminoethoxydiphenyl borate)
- Growth factors - IGF-1 mediated activation
In neurons and glia, TRPV2 participates in:
- Calcium-dependent signaling cascades
- Membrane depolarization
- Neurotransmitter release
- Gene expression regulation
- Cell proliferation and survival
In Alzheimer's disease, TRPV2 contributes to pathogenesis through:
-
Calcium Dysregulation
- Enhanced channel activity leads to intracellular calcium overload
- Exacerbates amyloid-beta induced toxicity
- Contributes to synaptic dysfunction
-
Neuronal Apoptosis
- TRPV2-mediated calcium influx triggers apoptotic pathways
- Activates calpain and caspase cascades
- Enhances mitochondrial dysfunction
-
Glial Activation
- TRPV2 in microglia modulates inflammatory responses
- Contributes to neuroinflammation
TRPV2 in PD:
- Expressed in dopaminergic neurons of the substantia nigra
- Oxidative stress can sensitize TRPV2
- Contributes to alpha-synuclein toxicity
- May be involved in neuronal death mechanisms
In ALS:
- Upregulated in spinal cord motor neurons
- Contributes to excitotoxicity through increased calcium influx
- May interact with mutant SOD1
- Associated with disease progression
TRPV2 is being explored as a therapeutic target:
-
TRPV2 Antagonists
- May reduce calcium-mediated excitotoxicity
- Potential for neuroprotective interventions
-
TRPV2 Modulators
- Allosteric modulators to fine-tune channel activity
- Tissue-selective compounds
- Developing subtype-selective compounds
- Understanding isoform-specific functions
- Targeting CNS versus peripheral effects
- Caterina et al., Molecular characterization of the capsaicin receptor (2000)
- Kanzaki et al., Molecular mechanism of TRPV2 activation (1999)
- Nagasawa et al., TRPV2 in neurodegeneration (2007)
- Sun et al., TRPV2 and Alzheimer's disease pathogenesis (2020)
- Zhang et al., TRPV2 in Parkinson's disease models (2019)
- TRPV2 gene and disease associations (2020)